Fig. 2. Methylation-specific PCR analysis of the DACT1 promoter from normal and bladder cancer tissues.
The MSP assay showed that the frequency of hypermethylaion was 25% and 58.62% in normal tissue and bladder cancer tissues, respectively. DACT1 was hypermethylated in most bladder cancer tissues, and unmethylated in normal tissues. *P < 0.05.